Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands.
Eur Heart J. 2012 Jun;33(11):1367-77. doi: 10.1093/eurheartj/ehs034. Epub 2012 Mar 4.
Limited information is available regarding the relationship between coronary vessel dominance and prognosis. Therefore, the purpose of this study was to determine the prognostic value of coronary vessel dominance in relation to significant coronary artery disease (CAD) in patients referred for computed tomography coronary angiography (CTA).
The study population consisted of 1425 patients (869 men, 57 ± 12 years) referred for CTA. To evaluate the impact of vessel dominance and significant CAD on CTA on outcome, patients were followed during a median period of 24 months for the occurrence of non-fatal myocardial infarction and all-cause mortality. The presence of a left dominant system was identified as a significant predictor for non-fatal myocardial infarction and all-cause mortality (HR: 3.20; 95% CI: 1.67-6.13, P < 0.001) and had incremental value over baseline risk factors and severity of CAD on CTA. In addition, in the subgroup of patients with significant CAD on CTA, patients with a left dominant system had a worse outcome compared with patients with a right dominant system (cumulative event rates: 9.5% and 35% at 3-year follow-up for a right and left dominant coronary artery system, respectively, log-rank P < 0.001).
The presence of a left dominant system was identified as an independent predictor of non-fatal myocardial infarction and all-cause mortality, especially in patients with significant CAD on CTA. Therefore, the assessment of coronary vessel dominance on CTA may further enhance risk stratification beyond the assessment of significant CAD on CTA.
关于冠状动脉优势与预后之间的关系,目前相关信息有限。因此,本研究旨在确定在接受计算机断层扫描冠状动脉造影(CTA)检查的患者中,冠状动脉优势与严重冠状动脉疾病(CAD)之间的相关性与预后的关系。
本研究人群包括 1425 名患者(869 名男性,57±12 岁),他们因 CTA 检查而被转诊。为了评估优势血管和 CTA 检查中显著 CAD 对预后的影响,在中位随访 24 个月期间,对患者进行了非致死性心肌梗死和全因死亡率的随访。左优势系统的存在被确定为非致死性心肌梗死和全因死亡率的显著预测因子(HR:3.20;95%CI:1.67-6.13,P<0.001),并具有超过基线风险因素和 CTA 检查中 CAD 严重程度的增量价值。此外,在 CTA 检查中存在显著 CAD 的患者亚组中,与右优势系统的患者相比,左优势系统的患者预后更差(累积事件发生率:3 年随访时,右优势和左优势冠状动脉系统分别为 9.5%和 35%,对数秩 P<0.001)。
左优势系统的存在被确定为非致死性心肌梗死和全因死亡率的独立预测因子,尤其是在 CTA 检查中存在显著 CAD 的患者。因此,在 CTA 检查中评估冠状动脉优势可能会进一步增强风险分层,超过 CTA 检查中对显著 CAD 的评估。